Table 2.
Comparing patient information between distant and localized/regional stage diagnoses
| Total Count | Distant (n = 286) | Localized/Regional (n = 2748) | |
|---|---|---|---|
| Variables | N (col %) | N (col %) | |
| Number of PATIENTS | |||
| 3034 | 286 (9.4) | 2748 (90.6) | |
| Age at diagnosis (in years) | |||
| 68–74 | 1923 | 95 (33.2) | 1828 (66.5) |
| 75–84 | 945 | 119 (41.6) | 826 (30.1) |
| ≥ 85 | 166 | 72 (25.2) | 94 (3.4) |
| Race | |||
| White | 2686 | 248 (86.7) | 2438 (88.7) |
| Non-white | 348 | 38 (13.3) | 310 (11.3) |
| Marital status | |||
| Married | 2174 | 172 (60.1) | 2002 (72.9) |
| Separated/divorced | > 193* | > 24 (> 8.4)* | < 170 (> 6.2)* |
| Widowed | 265 | 51 (17.8) | 214 (7.8) |
| Single | 237 | 28 (9.8) | 209 (7.6) |
| Unknown | < 165* | < 11 (< 3.8)* | > 153 (> 5.6)* |
| Geographic area | |||
| Metropolitan | 2005 | 189 (66.1) | 1816 (65.2) |
| Appalachian | 524 | 51 (17.8) | 473 (17.0) |
| Rural | 505 | 46 (16.1) | 459 (16.5) |
| Area poverty level | |||
| < 5% | 899 | 75 (26.2) | 824 (29.6) |
| 5.00–9.99% | 812 | 72 (25.2) | 740 (26.6) |
| 10.00–19.99% | 836 | 82 (28.7) | 754 (27.1) |
| ≥ 20% | 487 | 57 (19.9) | 430 (15.4) |
| Claims-based frailty index | |||
| Non-frail (score < 0.1) | 630 | 18 (6.3) | 612 (22.3) |
| Pre-frail (0.1–0.19) | 2189 | 222 (77.6) | 1967 (71.6) |
| Mildly-severely frail (score ≥ 0.20) | 215 | 46 (16.1) | 169 (6.1) |
| PSA testing in 3 years prior to cancer diagnosis | |||
| Screening | 1884 | 121 (42.3) | 1763 (63.3) |
| Diagnostic | 1150 | 165 (57.7) | 985 (36.7) |
*In accordance with our data users’ agreement, cell sizes < 11 were masked to prevent re-identification of subjects. Other cells in the corresponding rows and columns were masked to prevent the derivation of the masked cells